OptiNose

OptiNose is dedicated to improving the lives of patients with chronic rhinitis-related diseases by developing unique nasal drug delivery systems and several new drug candidates. Its product development primarily relies on its proprietary novel nasal drug delivery technology, Bi-Directional™ Breath Powered® technology. When people exhale forcefully through their mouths, the soft palate closes off the airway to the nasal cavity. OptiNose’s drug delivery device utilizes this natural human breathing mechanism to create a closed palate, allowing the drug to circulate within an enclosed space and be delivered deep into the nasal cavity. The device can deliver liquid or powdered medications, requires smaller doses, enables faster absorption into the bloodstream, eliminates the need for injections, and is more convenient to use.